Systemic cyclosporin A prophylaxis after keratoplasties with an elevated risk for immune reactions as the only elevated risk factor;Systemische Cyclosporin-A-Prophylaxe nach Keratoplastiken mit erhohtem Risiko fur Immunreaktionen als einzigem erhohten Risikofaktor

Ophthalmologe

Volumn 94, Issue 7, 1997, Pages 496-500

  Reinhard, Thomas ^a   Sundmacher, Rainer ^a   Godehardt, Erhard ^b   Heering, Peter ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cydosporin A; High risk keratoplasty; Immune reactions

Indexed keywords

CYCLOSPORIN A;

ARTICLE; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INFECTION RISK; KERATOPLASTY; MAJOR CLINICAL STUDY; PROGNOSIS; REACTION ANALYSIS; RISK FACTOR;

CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0030818191     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050146     Document Type: Article

References (11)

1. Gnad HD, Skorpik C, Radda TM, Pa roussis P, Menapace R, Klemen UM (1985) Immunsuppressive Therapie mit Cyclosporin A nach perforierender Keratoplastik. Klin Monatsbl Augenheilkd 187:398-399
2. Hill JC (1989) The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol 107:506-510
3. Hill JC (1994) Systemic cyclosporine in high-risk keratoplasty. Short-versus long-term therapy. Ophthalmology 101:128-133
4. Irschick EU, Siepe U, Pöttinger E, Daxer A, Ulmer H, Falk M, Göttinger W (1994) Eight years follow-up of high-risk corneal allograft recipients under a three months course of cyclosporin A. Invest Ophthalmol Vis Sci 35:1876
5. Miller K, Kieselbach GF, Niederwieser D, Huber C, Margreiter R, Göttinger W (1985) Immunsuppression mit Cyclosporin A bei Risikokeratoplastiken. Klin Monatsbl Augenheilkd 187:394-397
6. Rehany U (1992) Suppression of allograft rejection in heavily vascularized human corneas. 2nd international symposium on ocular inflammation, Jerusalem, 30.8.1992-3.9.1992
7. Rossa V, Sundmacher R, Heering P (1990) Systemische Cyclosporin A Prophylaxe bei Risiko-Keratoplastiken. Klin Monatsbl Augenheilkd 197:466-469
8. Reinhard T, Sundmacher R, Heering P (1996) Systemic cyclosporin A in high-risk keratoplasties. Graefes Arch Clin Exp Ophthalmol 234:115-121
9. Reinhard T, Hutmacher M, Sundmacher R (1997) Akute und chronische Immunreaktionen nach perforierender Keratoplastik mit normalem Immunrisiko. Klin Monatsbl Augenheilkd 210:139-143
10. Sundmacher R, Reinhard T, Heering P (1992) Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. Ger J Ophthalmol 1:432-436
11. Völker-Dieben HJ, D'Amaro J, Slooten H, Kruit PJ (1994) The effect of cyclosporin-A on corneal graft survival. In: Zierhut M, Pleyer U, Thiel HJ (eds) Immunology of corneal transplantation. Aeolus Press, Buren, pp 239-252